MoneyWorks4Me

Ajanta Pharma reports Profit after tax of Rs 1968.50 Mln, in the September 2021 quarter

29 Oct 2021 Evaluate
The September 2021 quarter revenue stood at Rs. 8237.10 millions, up 21.76% as compared to Rs. 6765.10 millions during the corresponding quarter last year.The Company's Net profit for the September 2021 quarter have declined marginally to Rs. 1968.50  millions as against Rs. 2252.20 millions reported during the corresponding quarter ended.Operating profit for the quarter ended September 2021 decreased to 2852.60 millions as compared to 3370.80 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 8237.10 6765.10 21.76 15664.30 12373.60 26.59 27185.90 21964.20 23.77
Other Income 524.10 862.40 -39.23 834.10 993.40 -16.04 1035.70 1842.00 -43.77
PBIDT 2852.60 3370.80 -15.37 5492.80 5236.10 4.90 10204.80 7169.80 42.33
Interest 0.70 13.50 -94.81 12.40 25.50 -51.37 69.00 91.00 -24.18
PBDT 2851.90 3357.30 -15.05 5480.40 5210.60 5.18 10135.80 7039.60 43.98
Depreciation 304.00 272.00 11.76 601.60 540.60 11.28 1114.90 912.90 22.13
PBT 2547.90 3085.30 -17.42 4878.80 4670.00 4.47 9020.90 6126.70 47.24
TAX 579.40 833.10 -30.45 975.70 1260.90 -22.62 2264.50 1715.40 32.01
Deferred Tax 30.80 91.60 -66.38 63.40 138.70 -54.29 97.70 34.50 183.19
PAT 1968.50 2252.20 -12.60 3903.10 3409.10 14.49 6756.40 4411.30 53.16
Equity 173.90 175.40 -0.86 173.90 175.40 -0.86 173.90 175.40 -0.86
PBIDTM(%) 34.63 49.83 -30.50 35.07 42.32 -17.14 37.54 32.64 14.99
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..